Ipca Laboratories Share Price
1965.00+8.90 (+0.45%)
+45.34% past 1 Year
News
Ipca Lab plans capacity expansion, R&D and API facility upgrades
Equity
IPCALAB
Ipca Labs raises FY27 EBITDA margin guidance to 23 percent
Equity
IPCALAB
Ipca Labs reports higher Q1 revenue at Rs 2,800 crores
Equity
IPCALAB
Ipca Lab reports stronger Q1 EBITDA and margin expansion
Equity
IPCALAB
Ipca Labs Q1 net profit rises to Rs 400 crores
Equity
IPCALAB
Ipca Laboratories sees Rs 49.11 crore NSE block trade at Rs 1,875
Equity
IPCALAB
Ipca Laboratories sees Rs 51.45 crore NSE block trade at slight premium
Equity
IPCALAB
Ipca Laboratories sees Rs 16.94 crore NSE block trade in equity shares
Equity
IPCALAB
Ipca Laboratories inks global licensing agreement with Bhami’s Research Laboratory
Equity
IPCALAB
Ipca partners with Bhami Research on monoclonal antibodies licensing deal
Equity
IPCALAB
Ipca Laboratories informs about newspaper publication
Equity
IPCALAB
Ipca Laboratories sees Rs 90.35 crores NSE block trade in large deal
Equity
IPCALAB
Ipca Labs outlines FY27 growth guidance and margin expansion targets
Equity
IPCALAB
Ipca Labs sees higher Unichem US growth and margin outlook by FY27
Equity
IPCALAB
Ipca Laboratories informs about revised link for Q4FY26 conference call
Equity
IPCALAB
Ipca Laboratories schedules Q4 FY earnings concall for investor interaction today
Equity
IPCALAB
Ipca Laboratories - Quaterly Results
Equity
IPCALAB
Ipca Laboratories reports Profit after tax of 262.29 Crores, in the March 2026 quarter
Equity
IPCALAB
Ipca Labs FY26 revenue growth lags company’s stated guidance range
Equity
IPCALAB
Ipca Laboratories reports Q4 FY26 revenue growth driven by higher sales base
Equity
IPCALAB